Avivagen (CVE:VIV) Trading Down 4.5%

Avivagen Inc (CVE:VIV)’s stock price traded down 4.5% during trading on Thursday . The stock traded as low as C$0.63 and last traded at C$0.63, 22,000 shares were traded during trading. A decline of 48% from the average session volume of 42,169 shares. The stock had previously closed at C$0.66.

The company’s 50 day moving average price is C$0.59 and its 200 day moving average price is C$0.69. The company has a quick ratio of 1.67, a current ratio of 2.07 and a debt-to-equity ratio of 2,402.32. The firm has a market capitalization of $20.94 million and a price-to-earnings ratio of -4.09.

Avivagen (CVE:VIV) last posted its quarterly earnings data on Friday, September 6th. The company reported C($0.04) EPS for the quarter. The firm had revenue of C$0.01 million for the quarter. As a group, analysts expect that Avivagen Inc will post 1.05 earnings per share for the current year.



Avivagen Company Profile (CVE:VIV)

Avivagen Inc develops and commercializes various products to replace antibiotics in livestock feeds to optimize the health and growth of the animals by supporting the animal's own health defenses. The company offers products based on its OxC-Beta technology, such as OxC-beta Livestock, a premix for livestock feeds; and Vivamune Health Chews supplements for companion animals.

Featured Article: Operating Income

Receive News & Ratings for Avivagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avivagen and related companies with MarketBeat.com's FREE daily email newsletter.